# Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation

**Authors:** Fengxiang Yu, Ping Gong, Zhuqin Hu, Yu Qiu, Yongyao Cui, Xiaoling Gao, Hongzhuan Chen, Juan Li

PMC · DOI: 10.1186/s12974-015-0343-3 · 2015-06-24

## TL;DR

Copper ions increase the harmful effects of Alzheimer's peptides on brain immune cells, leading to increased inflammation and nerve damage.

## Contribution

Demonstrates that Cu(II) binding to Aβ peptides enhances microglial activation and neurotoxicity through NF-κB and mitochondrial ROS.

## Key findings

- Cu(II)-Aβ complex induces microglial activation and release of TNF-α and nitric oxide.
- NF-κB activation and mitochondrial ROS are involved in Cu(II)-Aβ-induced neurotoxicity.
- N-acetyl-cysteine inhibits Cu(II)-Aβ-triggered microglial neurotoxic effects.

## Abstract

Aggregated forms of amyloid-β (Aβ) peptides are important triggers for microglial activation, which is an important pathological component in the brains of Alzheimer’s patients. Cu(II) ions are reported to be coordinated to monomeric Aβ, drive Aβ aggregation, and potentiate Aβ neurotoxicity. Here we investigated whether Cu(II) binding modulates the effect of Aβ on microglial activation and the subsequent neurotoxicity.

Aβ peptides were incubated with Cu(II) at an equimolar ratio to obtain the Cu(II)-Aβ complex. Primary and BV-2 microglial cells were treated with Cu(II)-Aβ, Aβ, or Cu(II). The tumor necrosis factor-α (TNF-α) and nitric oxide levels in the media were determined. Extracellular hydrogen peroxide was quantified by a fluorometric assay with Amplex Red. Mitochondrial superoxide was detected by MitoSOX oxidation.

Incubation of Cu(II) with Aβ confers different chemical properties on the resulting complex. At the subneurotoxic concentrations, Cu(II)-Aβ (but not Aβ or Cu(II) alone) treatment induced an activating morphological phenotype of microglia and induced the microglial release of TNF-α and nitric oxide as well as microglia-mediated neuronal damage. Cu(II)-Aβ-triggered microglial activation was blocked by nuclear factor (NF)-κB inhibitors and was accompanied with NF-κB activation. Moreover, Cu(II)-Aβ induced hydrogen peroxide release, which was not affected by NADPH oxidase inhibitors. Mitochondrial superoxide production was increased after Cu(II)-Aβ stimulation. N-acetyl-cysteine, a scavenger of reactive oxygen species (ROS), inhibited Cu(II)-Aβ-elicited microglial release of TNF-α and nitric oxide as well as the microglia-mediated neurotoxic effect.

Our observations suggest that Cu(II) enhances the effect of Aβ on microglial activation and the subsequent neurotoxicity. The Cu(II)-Aβ-triggered microglial activation involves NF-κB activation and mitochondrial ROS production.

The online version of this article (doi:10.1186/s12974-015-0343-3) contains supplementary material, which is available to authorized users.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor)
- **Chemicals:** Cu(II) (PubChem CID 27099), N-acetyl-cysteine (PubChem CID 12035), Amplex Red (PubChem CID 167453)

## Full-text entities

- **Genes:** Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Anxa11os (annexin A11, opposite strand) [NCBI Gene 105245705] {aka Gm9872}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, Ikbkb (inhibitor of kappaB kinase beta) [NCBI Gene 16150] {aka IKK-2, IKK-B, IKK-beta, IKK2, IKK[b], IKKbeta}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** Dendritic damage (MESH:D007635), behavioral deficits (MESH:D019958), inflammatory (MESH:D007249), synaptic dysfunction (MESH:C536122), amyloid fibrils (MESH:D014693), cerebral acidosis (MESH:D000138), neurotoxic (MESH:D020258), mtROS (MESH:D000860), neurodegeneration (MESH:D019636), amyloid plaques (MESH:D058225), Neuroinflammation (MESH:D000090862), AD (MESH:D000544), CM (MESH:D010033), necrotic death (MESH:D003643), neuronal damage (MESH:D009410), TBST (OMIM:615707)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** BV-2 — Mus musculus (Mouse), Transformed cell line (CVCL_0182), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4490619/full.md

---
Source: https://tomesphere.com/paper/PMC4490619